BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Zheng R, Li H, Guo J. Serum uric acid and incident atrial fibrillation: A systematic review and dose-response meta-analysis. Clin Exp Pharmacol Physiol 2020;47:1774-82. [PMID: 32621546 DOI: 10.1111/1440-1681.13374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao Z, Shi H, Xu W, Guan Z, Su X, Guo N, Ma H, Senesi P. Hyperuricemia Increases the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis. International Journal of Endocrinology 2022;2022:1-10. [DOI: 10.1155/2022/8172639] [Reference Citation Analysis]
2 Chen J, Lyu L, Shen J, Pan Y, Jing J, Wang YJ, Wei T. Epidemiological study of calcified aortic valve stenosis in a Chinese community population. Postgrad Med J 2022:postgradmedj-2022-141721. [PMID: 35879093 DOI: 10.1136/pmj-2022-141721] [Reference Citation Analysis]
3 Xiong J, Shao W, Yu P, Ma J, Liu M, Huang S, Liu X, Mei K. Hyperuricemia Is Associated With the Risk of Atrial Fibrillation Independent of Sex: A Dose-Response Meta-Analysis. Front Cardiovasc Med 2022;9:865036. [DOI: 10.3389/fcvm.2022.865036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Pezzo MP, Tufano A, Franchini M. Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation. J Clin Med 2022;11:915. [PMID: 35207188 DOI: 10.3390/jcm11040915] [Reference Citation Analysis]
5 Li Y, Zhu X, Liu F, Peng W, Zhang L, Li J. Pharmacodynamic evaluation of the XOR inhibitor WN1703 in a model of chronic hyperuricemia in rats induced by yeast extract combined with potassium oxonate. Current Research in Pharmacology and Drug Discovery 2022;3:100098. [DOI: 10.1016/j.crphar.2022.100098] [Reference Citation Analysis]
6 Vrachatis DA, Papathanasiou KA, Iliodromitis KE, Giotaki SG, Kossyvakis C, Raisakis K, Kaoukis A, Lambadiari V, Avramides D, Reimers B, Stefanini GG, Cleman M, Giannopoulos G, Lansky A, Deftereos SG. Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations. Drugs 2021;81:1381-95. [PMID: 34297330 DOI: 10.1007/s40265-021-01565-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Shang L, Zhang L, Guo Y, Sun H, Zhang X, Bo Y, Zhou X, Tang B. A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation. Front Cardiovasc Med 2021;8:682538. [PMID: 34277733 DOI: 10.3389/fcvm.2021.682538] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Wełnicki M, Gorczyca I, Wójcik W, Jelonek O, Maciorowska M, Uziębło-Życzkowska B, Wójcik M, Błaszczyk R, Rajtar-Salwa R, Tokarek T, Bil J, Wojewódzki M, Szpotowicz A, Krzciuk M, Gawałko M, Kapłon-Cieślicka A, Tomaszuk-Kazberuk A, Szyszkowska A, Bednarski J, Bakuła-Ostalska E, Wożakowska-Kapłon B, Mamcarz A. Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study. J Clin Med 2021;10:1829. [PMID: 33922386 DOI: 10.3390/jcm10091829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Deng Y, Liu F, Yang X, Xia Y. The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation. Front Cardiovasc Med 2021;8:641136. [PMID: 33718459 DOI: 10.3389/fcvm.2021.641136] [Cited by in F6Publishing: 9] [Reference Citation Analysis]